| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRUS | Merus N.V. | Lundberg Sven Ante | President, CEO & PFO | Nov 03, 2022 | Buy | $14.38 | 14,706 | 211,431 | 40,576 | Nov 03, 2022, 02:07 PM | |
| MRUS | Merus N.V. | Lundberg Sven Ante | President, CEO & PFO | Aug 22, 2022 | Buy | $22.92 | 5,826 | 133,558 | 25,870 | Aug 23, 2022, 04:09 PM | |
| MRUS | Merus N.V. | Lundberg Sven Ante | President, CEO & PFO | Aug 19, 2022 | Buy | $22.99 | 704 | 16,187 | 20,044 | Aug 22, 2022, 03:02 PM | |
| MRUS | Merus N.V. | Lundberg Sven Ante | President, CEO & PFO | Jul 12, 2022 | Buy | $22.97 | 4,340 | 99,685 | 19,340 | Jul 13, 2022, 10:13 AM | |
| MRUS | Merus N.V. | Lundberg Sven Ante | President, CEO & PFO | Aug 02, 2021 | Option Exercise | $13.36 | 15,000 | 200,474 | 15,000 | Aug 04, 2021, 03:56 PM | |
| MRUS | Merus N.V. | Lundberg Sven Ante | President, CEO & PFO | Mar 01, 2021 | Option Exercise | $13.38 | 74,000 | 989,867 | 74,000 | Mar 03, 2021, 12:00 AM | |
| CRSP | CRISPR Therapeutics AG | Lundberg Sven Ante | Chief Scientific Officer | Oct 24, 2016 | Buy | $14.00 | 400 | 5,600 | 505,617 | Feb 10, 2017, 02:16 PM |
Menu